Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Aug 30, 2018 5:16pm
78 Views
Post# 28545505

RE:Cannabis opportunity

RE:Cannabis opportunitybecause they might actually make money if they did that?

Ciao wrote: As others have mentioned before. Here is Tilray's CEO on the same topic,

“I think most products will be in form factors more similar to other pharmaceuticals, other CPG products,” he says. “People will drink cannabis instead of beer; people will drink a product with zero or few calories and no hangover, and they’ll drink it instead of a beer in a bar or at their homes. They may eat a product in the form of a chocolate bar or consume a pill. And so, that’s where the value is, in the intellectual property of these other form factors and other delivery mechanisms.”

As to the growing investment interest from industries such as beer and alcohol companies, Kennedy says that it’s all part of bringing in a brand new sector of the economy.

From my understanding CZO was upgrading its facilities to be pharma grade P3A (beyond food grade), so it's hard to understand why they are not partnering to investigate the use of PGX in food or pharma with eventual licensing of their tech.



Bullboard Posts